Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells

We have recently demonstrated the safety and tolerability of a novel therapeutic regimen employing autologous blood cells chemically coupled with seven myelin peptides to induce antigen-specific tolerance in MS (ETIMS study). The aim of the current study was an extended safety analysis to assess the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Multiple sclerosis Ročník 21; číslo 5; s. 651 - 655
Hlavní autoři: Peschl, Patrick, Reindl, Markus, Schanda, Kathrin, Sospedra, Mireia, Martin, Roland, Lutterotti, Andreas
Médium: Journal Article
Jazyk:angličtina
Vydáno: London, England SAGE Publications 01.04.2015
Sage Publications Ltd
Témata:
ISSN:1352-4585, 1477-0970, 1477-0970
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:We have recently demonstrated the safety and tolerability of a novel therapeutic regimen employing autologous blood cells chemically coupled with seven myelin peptides to induce antigen-specific tolerance in MS (ETIMS study). The aim of the current study was an extended safety analysis to assess the effect of the ETIMS approach on antibodies to common autoantigens, the myelin peptides used and common recall antigens. None of the patients showed induction of autoantibody responses. One patient had a measurable myelin peptide-specific response at baseline, which was reduced after treatment. Total immunoglobulins and recall antibody responses showed no significant change.
Bibliografie:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1352-4585
1477-0970
1477-0970
DOI:10.1177/1352458514549405